News
These properties make SA invaluable in biomolecule capture and enrichment in analytical applications such as ELISA, protein ...
Phase I Trial of EC90 (keyhole-limpet hemocyanin fluorescein isothiocyanate conjugate) with GPI-0100 adjuvant followed by EC 17 (folate-fluorescein isothiocyanate conjugate) in patients with ...
Fluorescein isothiocyanate–labeled zymosan (Invitrogen) or Rhodamine Green-X–labeled live C. albicans SC5314 were used in recognition assays at macrophage/particle ratios of 25:1 for zymosan ...
To the Editor: A 68-year-old man was referred to our hospital in 2008 because of a progressive onset of profound asthenia. Macrocytic anemia was evident with signs of hemolysis and recurrent hyperc ...
Scientists demonstrate an innovative acoustofluidics-based approach for intracellular nanoparticle delivery. This method offers a new way to transport various functional nanomaterials into different ...
Fluorescein angiography is a test for your eyes. Learn about how it’s done, what to expect, why it’s done, and more.
Fluorescein angiography (FA) is a diagnostic imaging technique. To perform it, eye doctors use a special dye and camera to view the back of the eye. This enables them to detect and monitor various ...
Hosted on MSN3mon
How to Make Fluorescein from Highlighter Markers - MSNThis video demonstrates how to extract the chemical fluorescein from highlighter markers using no other chemical besides common rubbing alcohol. As is demonstrated in the video, fluorescein is ...
For example, the most widely used fluorochrome, Fluorescein isothiocyanate (FITC), has a peak absorbance of 494nm and a peak emission of 512nm corresponding to the colors blue and green.
In addition, all available antibodies can be supplied in an unconjugated format, or preconjugated to either FITC (fluorescein isothiocyanate) or HRP (horseradish peroxidase).
Phase I trial of EC90 (keyhole-limpet hemocyanin fluorescein isothiocyanate conjugate) with GPI-0100 adjuvant followed by EC17 (Folate-Fluorescein Isothiocyanate Conjugate) in Patients (pts) with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results